amag-423
Generic: digoxin immune fab (ovine)
amag-423: developed by 1 company. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| AMAG PHARMACEUTICALS, INC. (AMAG) | Phase 2/Phase 3 |
Get deeper analysis on amag-423
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis